Scott M. Herbig

Person

Becd, OR, US

People

Patents Grantslast 30 patents

Information Patent Grant
Tofacitinib oral sustained release dosage forms
- Patent number 11,253,523
- Issue date Feb 22, 2022
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tofacitinib oral sustained release dosage forms
- Patent number 10,639,309
- Issue date May 5, 2020
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tofacitinib oral sustained release dosage forms
- Patent number 9,937,181
- Issue date Apr 10, 2018
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid pharmaceutical dispersions with enhanced bioavailability
- Patent number 8,431,159
- Issue date Apr 30, 2013
- Bend Research, Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid pharmaceutical dispersions with enhanced bioavailability
- Patent number 8,367,118
- Issue date Feb 5, 2013
- Bend Research, Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid pharmaceutical dispersions with enhanced bioavailability
- Patent number 8,337,899
- Issue date Dec 25, 2012
- Bend Research, Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid pharmaceutical dispersions with enhanced bioavailability
- Patent number 8,263,128
- Issue date Sep 11, 2012
- Bend Research, Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid pharmaceutical dispersions with enhanced bioavailability
- Patent number 8,257,741
- Issue date Sep 4, 2012
- Bend Research, Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multiparticulate crystalline drug compositions having controlled re...
- Patent number 7,887,844
- Issue date Feb 15, 2011
- Pfizer Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Controlled release by extrusion of solid amorphous dispersions of d...
- Patent number 7,550,158
- Issue date Jun 23, 2009
- Bend Research, Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Azithromycin dosage forms with reduced side effects
- Patent number 6,984,403
- Issue date Jan 10, 2006
- Pfizer Inc.
- Timothy A. Hagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Controlled release by extrusion of solid amorphous dispersions of d...
- Patent number 6,706,283
- Issue date Mar 16, 2004
- Pfizer Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sustained release formulations for growth hormone secretagogues
- Patent number 6,641,840
- Issue date Nov 4, 2003
- Pfizer Inc.
- Mary T. Am Ende
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sertraline salts and sustained-release dosage forms of sertraline
- Patent number 6,517,866
- Issue date Feb 11, 2003
- Pfizer Inc.
- Mary Tanya Am Ende
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of interfacially-polymerized membranes in delivery devices
- Patent number 5,876,752
- Issue date Mar 2, 1999
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Osmotic devices having vapor-permeable coatings
- Patent number 5,827,538
- Issue date Oct 27, 1998
- Pfizer Inc.
- Edward L. Cussler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Labile insecticide compositions
- Patent number 5,750,126
- Issue date May 12, 1998
- Bend Research, Inc.
- Kelly L. Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Asymmetric membranes in delivery devices
- Patent number 5,698,220
- Issue date Dec 16, 1997
- Pfizer Inc.
- John R. Cardinal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of asymmetric membranes in delivery devices
- Patent number 5,612,059
- Issue date Mar 18, 1997
- Pfizer Inc.
- John R. Cardinal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PH-triggered osmotic bursting delivery devices
- Patent number 5,609,590
- Issue date Mar 11, 1997
- Pfizer Inc.
- Scott M. Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Supported liquid membrane delivery devices
- Patent number 5,603,953
- Issue date Feb 18, 1997
- Pfizer Inc.
- Scott M. Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PH-triggered osmotic bursting delivery devices
- Patent number 5,358,502
- Issue date Oct 25, 1994
- Pfizer Inc.
- Scott M. Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adsorbents for the removal of volatile substances from aqueous systems
- Patent number 5,091,080
- Issue date Feb 25, 1992
- Bend Research, Inc.
- Paul van Eikeren
- C02 - TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE

Patents Applicationslast 30 patents

Information Patent Application
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
- Publication number 20220142927
- Publication date May 12, 2022
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
- Publication number 20200206232
- Publication date Jul 2, 2020
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY
- Publication number 20150024054
- Publication date Jan 22, 2015
- BEND RESEARCH, INC.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
- Publication number 20140271842
- Publication date Sep 18, 2014
- Pfizer Inc.
- Scott Max Herbig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY
- Publication number 20130224301
- Publication date Aug 29, 2013
- BEND RESEARCH, INC.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY
- Publication number 20120328679
- Publication date Dec 27, 2012
- Bend Research, Inc
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY
- Publication number 20120292797
- Publication date Nov 22, 2012
- Bend Research, Inc
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY
- Publication number 20120288542
- Publication date Nov 15, 2012
- Bend Research, Inc
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS, DOSAGE FORMS AND KITS FOR ADMINISTERING ZIPRASIDONE WITHOU...
- Publication number 20110002989
- Publication date Jan 6, 2011
- Pfizer Inc.
- William John Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS COMPRISING CELECOXIB PROVIDING BOTH RAPID AND SUSTAINE...
- Publication number 20100233272
- Publication date Sep 16, 2010
- Leah Elizabeth Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE
- Publication number 20100003331
- Publication date Jan 7, 2010
- Pfizer Inc.
- Imran Ahmed
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUS...
- Publication number 20080299188
- Publication date Dec 4, 2008
- Pfizer Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Enteric Coated Azithromycin Multiparticulates
- Publication number 20080199527
- Publication date Aug 21, 2008
- Pfizer Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dosage Forms Providing Controlled and Immediate Release of Choleste...
- Publication number 20080145427
- Publication date Jun 19, 2008
- Alfred Berchielli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZITHROMYCIN DOSAGE FORMS WITH REDUCED SIDE EFFECTS
- Publication number 20080015343
- Publication date Jan 17, 2008
- Pfizer Inc.
- Timothy A. Hagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release dosage forms of ziprasidone
- Publication number 20070190129
- Publication date Aug 16, 2007
- Pfizer Inc.
- Imran Ahmed
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Azithromycin dosage forms with reduced side effects
- Publication number 20060039988
- Publication date Feb 23, 2006
- Pfizer Inc.
- Timothy A. Hagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Azithromycin dosage forms with reduced side effects
- Publication number 20060029677
- Publication date Feb 9, 2006
- Pfizer Inc.
- Timothy A. Hagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multiparticulate crystalline drug compositions having controlled re...
- Publication number 20050181062
- Publication date Aug 18, 2005
- Pfizer Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Azithromycin multiparticulate dosage forms by melt-congeal processes
- Publication number 20050158391
- Publication date Jul 21, 2005
- Pfizer Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Azithromycin dosage forms with reduced side effects
- Publication number 20050123627
- Publication date Jun 9, 2005
- Pfizer Inc.
- Timothy A. Hagen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solubilized sertraline compositions
- Publication number 20040208926
- Publication date Oct 21, 2004
- Pfizer Inc.
- Dwayne Thomas Friesen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Controlled release by extrusion of solid amorphous dispersions of d...
- Publication number 20040175428
- Publication date Sep 9, 2004
- Pfizer Inc.
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Controlled-Release of an active substance into a high fat environment
- Publication number 20040121015
- Publication date Jun 24, 2004
- Pfizer Inc.
- Mark B. Chidlaw
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release formulations for growth hormone secretagogues
- Publication number 20040091530
- Publication date May 13, 2004
- Mary T. Am Ende
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hydrogel-driven drug dosage form
- Publication number 20040052845
- Publication date Mar 18, 2004
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid pharmaceutical dispersions with enhanced bioavailability
- Publication number 20030219489
- Publication date Nov 27, 2003
- Pfizer Inc.
- William J. Curatolo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hydrogel-driven drug dosage form
- Publication number 20030086972
- Publication date May 8, 2003
- Leah E. Appel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sustained release formulations for growth hormone secretagogues
- Publication number 20020137765
- Publication date Sep 26, 2002
- Mary T. Am Ende
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Solid pharmaceutical dispersions with enhanced bioavailability
- Publication number 20020009494
- Publication date Jan 24, 2002
- William J. Curatolo
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL

Scott M. Herbig

Person

Patents Grantslast 30 patents

Tofacitinib oral sustained release dosage forms

Tofacitinib oral sustained release dosage forms

Tofacitinib oral sustained release dosage forms

Solid pharmaceutical dispersions with enhanced bioavailability

Solid pharmaceutical dispersions with enhanced bioavailability

Solid pharmaceutical dispersions with enhanced bioavailability

Solid pharmaceutical dispersions with enhanced bioavailability

Solid pharmaceutical dispersions with enhanced bioavailability

Multiparticulate crystalline drug compositions having controlled re...

Controlled release by extrusion of solid amorphous dispersions of d...

Azithromycin dosage forms with reduced side effects

Controlled release by extrusion of solid amorphous dispersions of d...

Sustained release formulations for growth hormone secretagogues

Sertraline salts and sustained-release dosage forms of sertraline

Use of interfacially-polymerized membranes in delivery devices

Osmotic devices having vapor-permeable coatings

Labile insecticide compositions

Asymmetric membranes in delivery devices

Use of asymmetric membranes in delivery devices

PH-triggered osmotic bursting delivery devices

Supported liquid membrane delivery devices

PH-triggered osmotic bursting delivery devices

Adsorbents for the removal of volatile substances from aqueous systems

Patents Applicationslast 30 patents

TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS

TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

SOLID PHARMACEUTICAL DISPERSIONS WITH ENHANCED BIOAVAILABILITY

METHODS, DOSAGE FORMS AND KITS FOR ADMINISTERING ZIPRASIDONE WITHOU...

DOSAGE FORMS COMPRISING CELECOXIB PROVIDING BOTH RAPID AND SUSTAINE...

SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE

CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUS...

Enteric Coated Azithromycin Multiparticulates

Dosage Forms Providing Controlled and Immediate Release of Choleste...

AZITHROMYCIN DOSAGE FORMS WITH REDUCED SIDE EFFECTS

Sustained release dosage forms of ziprasidone

Azithromycin dosage forms with reduced side effects

Azithromycin dosage forms with reduced side effects

Multiparticulate crystalline drug compositions having controlled re...

Azithromycin multiparticulate dosage forms by melt-congeal processes

Azithromycin dosage forms with reduced side effects

Solubilized sertraline compositions

Controlled release by extrusion of solid amorphous dispersions of d...

Controlled-Release of an active substance into a high fat environment

Sustained release formulations for growth hormone secretagogues

Hydrogel-driven drug dosage form

Solid pharmaceutical dispersions with enhanced bioavailability

Hydrogel-driven drug dosage form

Sustained release formulations for growth hormone secretagogues

Solid pharmaceutical dispersions with enhanced bioavailability